)-galactofuranosyl residues located at the outer cell wall of the human pathogenic fungus Aspergillus fumigatus. FTGM contains a linear α-mannan structure called coremannan composed of 9 or 10 α-(1 → 2)-mannotetraose units jointed by α-(1 → 6)-linkages. However, the enzymes involved in core-mannan biosynthesis remain unknown. We speculated that two putative α-1,2-mannosyltransferase genes in A. fumigatus, Afu5g02740/AFUB_051270 (here termed coremannan synthase A [CmsA]) and Afu5g12160/AFUB_059750 (CmsB) are involved in FTGM core-mannan biosynthesis. We constructed recombinant proteins for CmsA and detected robust mannosyltransferase activity using the chemically synthesized substrate p-nitrophenyl α-d-mannopyranoside as an acceptor. Analyses of CmsA enzymatic product revealed that CmsA possesses the capacity to transfer a mannopyranoside to the C-2 position of α-mannose. CmsA could also transfer a mannose residue to α-(1 → 2)-mannobiose and α-(1 → 6)-mannobiose and showed a 31-fold higher specific activity toward α-(1 → 6)-mannobiose than toward α-(1 → 2)-mannobiose. Proton nuclear magnetic resonance ( 1 H-NMR) spectroscopy and gel filtration chromatography of isolated FTGM revealed that core-mannan structures were drastically altered and shortened in disruptant A. fumigatus strains ∆cmsA, ∆cmsB, and ∆cmsA∆cmsB. Disruption of cmsA or cmsB resulted in severely repressed hyphal extension, abnormal branching hyphae, formation of a balloon structure in hyphae, and decreased conidia formation. The normal wild type core-mannan structure and developmental phenotype were restored by the complementation of cmsA and cmsB in the corresponding disruptant strains. These findings indicate that both CmsA, an α-1,2-mannosyltransferase, and CmsB, a putative mannosyltransferase, are involved in FTGM biosynthesis.
, suggesting functions distinct from Mnt1. The Afu5g02740/AFUB_051270 and Afu5g12160/AFUB_059750 genes encode predicted 397-and 506-amino acid proteins with molecular masses of 46.5 and 58.9 kDa, respectively (Fig. 1A) . TMHMM predicted that both Afu5g02740/AFUB_051270 and Afu5g12160/AFUB_059750 have a transmembrane domain (amino acids 7-26 and 48-70, respectively) at the N-terminus, suggesting that these are type II membrane proteins (Fig. 1A ) 23 . Several glycosyltransferase families possess a DXD motif (where X represents any amino acid), which is necessary to coordinate the divalent cation 24 . The Mnt1/Kre2 and Ktr4 proteins of S. cerevisiae do not contain the archetypal DXD motif 25, 26 , but the EPD (amino acids 247-249) and EPN (amino acids 262-264) sequences have been claimed to serve the same purpose 25, 26 . The equivalent sequences in CmsA and CmsB were found in EPK (amino acids 205-207) and EPE (amino acids 245-247), as shown in Fig. 1A . The C-terminal side region of Afu5g12160/AFUB_059750 (amino acids 443-506) has no sequence similarity with any previously identified protein domain (Fig. 1A) . The Afu5g02740/AFUB_051270 gene is closely related to the genes encoding mannosyltransferases CaKtr4 and ScKtr4 putatively involved in N-glycosylation 20, 26, 27 , while Afu5g12160/ AFUB_059750 is closely related to the genes encoding the putative mannosyltransferases ScKtr5 and ScKtr7 20 . We hypothesized that these two putative α-1,2-mannosyltransferase genes are involved in biosynthesis of FTGM core-mannan. Therefore, we tentatively named Afu5g02740/AFUB_051270 core-mannan synthase A (CmsA) and Afu5g12160/AFUB_059750 core-mannan synthase B (CmsB) and attempted to elucidate their functions.
Enzymatic functions and properties of CmsA. We obtained recombinant CmsA protein using the E. coli expression system. Transcripts encoding the putative catalytic domains of CmsA (amino acids 27-397) and CmsB (amino acids 71-442) were introduced into an E. coli expression vector fused in-frame with a 6 × histidine (6 × His) tag at the N-terminus. CmsA was successfully expressed as a soluble protein in an E. coli, but CmsB was unfortunately expressed as an insoluble protein in an E. coli. Recombinant 6 × His-tagged CmsA protein was purified by Ni + affinity chromatography and gel filtration chromatography and analyzed using SDS-PAGE (Fig. 1B) . CmsA was visualized as bands of approximately 42 kDa, close to the predicted molecular weights of 45.4 kDa. Next, we measured mannosyltransferase activity at 37 °C using the chemically synthesized substrate p-nitrophenyl α-d-mannopyranoside (α-Man-pNP, 1.5 mM) as a sugar acceptor, guanosine diphosphate-α-d-mannose (GDP-Man, 1.5 mM) as a sugar donor, and 1.5 mM Mn 2+ as a cofactor ( Fig. 2A ). Reaction mixtures incubated for 24 h without CmsA did not yield any additional peaks on the chromatogram; by contrast, the reaction mixture with CmsA yielded an additional peak at 18.0 min, defined as peak-cmsA, suggesting the formation of enzymatic reaction product (defined as product-cmsA; Fig. 2A ). To determine the chemical structures of product-cmsA, we collected and digested the peak fraction using substrate-specific mannosidases (Fig. 2B ). Product-cmsA was digested by α-(1 → 2)-specific mannosidase but not by α-(1 → 6)-specific mannosidase ( Fig. 2B ), indicating that product-cmsA is α-Man-(1 → 2)-α-Man-pNP. Thus, CmsA has GDP-Man: α-mannoside α-1,2-mannosyltransferase activity in vitro. In addition, we attempted to evaluate the elongation activity of CmsA at 30 °C for 60 min using α-
as sugar acceptor substrates (Fig. 2C) . The reaction products were analyzed using HPLC after being labeled with 2-aminopyridine (PA). Remarkably, CmsA transferred a Man residue to both α-Man-(1 → 2)-α-Man and α-Man-(1 → 6)-α-Man to generate α-Man-(1 → 2)-α-Man-(1 → 2)-α-Man, and α-Man-(1 → 2)-α-Man-(1 → 6)-α-Man, respectively (Figs 2C and S1). That is because α-(1 → 2)-specific mannosidase digested the pyridylaminated product-α-(1 → 2)-M3 and product-α-(1 → 6)-M3 to generate α-Man-(1 → 2)-α-Man-PA and α-Man-(1 → 6)-α-Man-PA, respectively (Fig. S1 ). Consistent with the previous report, α-Man-(1 → 2)-α-Man-(1 → 2)-PA was resistant to the α-(1 → 2)-specific mannosidase (Fig. S1 ) 28 . Specific activities of CmsA toward α-(1 → 6)-mannobiose and α-(1 → 2)-mannobiose were 473 and 15.1 (nmol/min/mg protein), respectively. CmsA showed a 31-fold higher specific activity in the presence of α-(1 → 6)-mannobiose than in that of α-(1 → 2)-mannobiose under the same reaction conditions, indicating that CmsA recognizes α-(1 → 6)-mannobiose as a preferred acceptor substrate rather than α-(1 → 2)-mannobiose (Fig. 2C) .
The divalent metal ions required for CmsA activity were determined using established in vitro assays. First, the optimum temperature and pH for the enzyme reaction were determined. The optimum temperature was 40 °C, with activity decreasing sharply at higher temperatures of more than 50 °C (Fig. 3A) . The highest enzyme activity was observed in 100 mM Tris-HCl buffer at pH 8.0, with optimum CmsA activity in the range of pH 7.5-8.5 (Fig. 3B) (Fig. 3C ). Alternatively, no activity was detected in the presence of the divalent cation chelator EDTA. Thus, like many other mannosyltransferases, CmsA requires manganese ions for optimal enzymatic activity, indicating that CmsA belongs to the GT-A superfamily, the members of which typically contain a coordinated divalent cation 29 . Deletion of cmsA, cmsB, or both results in aberrant growth and developmental phenotypes.
To elucidate the functions of cmsA and cmsB, we constructed disruptant strains ∆cmsA, ∆cmsB, and ∆cmsA∆cmsB (∆cmsAB) ( Fig. S2 ; Table 1 ) as well as the strains complemented by the corresponding gene, ∆cmsA::cmsA for ∆cmsA and ∆cmsB::cmsB for ∆cmsB ( Fig. S3 ; Table 1 ). The disruptants exhibited impaired growth, hyphal extension, and conidial formation (Figs 4A,B and 5A,B). Strains ∆cmsA, ∆cmsB, and ∆cmsAB formed smaller colonies than the wild type (WT) strain A1151 after cultivation on minimal medium (MM) at 37 °C for 36 h (Fig. 4A) , and colony growth rates were markedly reduced (in mm/h, WT: 0.72 ± 0.11 vs. ∆cmsA: 0.074 ± 0.03, ∆cmsB: 0.058 ± 0.01, ∆cmsAB: 0.056 ± 0.02 mm/h; Fig. 5A ). ∆cmsA::cmsA and ∆cmsB::cmsB rescued colony growth rates to near-WT levels (in mm/h, ∆cmsA::cmsA: 0.71 ± 0.09, ∆cmsB::cmsB: 0.67 ± 0.11) (Fig. 5A ). Conidiophores grown on MM plates at 37 °C for 3 days were then examined by microscopy ( Fig. 4B ). Conidiophores of strains ∆cmsA, ∆cmsB, and ∆cmsAB were sparse and scattered compared with WT conidiophores (Fig. 4B, left panels) . Aberrant conidiophores, which are vesicles without phialide, were observed in all three disruptants (Fig. 4B) . Some of the aberrant conidiophores formed the abnormal swelling structure on the tip or side of vesicles of all three disruptants (Fig. 4B) . The number of conidia per a conidiophore was lower for all three disruptants compared with that of the WT (Fig. 4B) . Indeed, the number of conidia per unit area after 3 days on MM at 37 °C was substantially lower for all three disruptants compared with the WT (in conidia/mm 2 (Fig. 5B) .
Structures of the vegetative hyphae were also investigated using microscopy after 3 days on MM at 37 °C (Fig. 6 ). The hyphae of WT A. fumigatus grew linearly, whereas ∆cmsA, ∆cmsB, and ∆cmsAB strains exhibited abnormal swelling (balloon-like structures) and branching (Fig. 6 ). Taken together, these observations suggest that cmsA and cmsB are essential for normal hyphae formation and conidiophore development. Table 2 ). The ∆cmsA, ∆cmsB, and ∆cmsAB strains exhibited only slightly greater sensitivity to AMPH-B, ITCZ, and MCZ compared with the WT strain ( Table 2) . However, compared with the WT strain, ∆cmsA exhibited 8-to 16-fold greater 5-FC sensitivity and ∆cmsB exhibited 4-fold greater 5-FC sensitivity ( Table 2) .
Neither CmsA nor CmsB is involved in α-(1 → 2)-mannosyl residue transfer for OMGM biosynthesis in vivo. Because α-(1 → 2)-mannosyl residues are present in both FTGM and OMGM 6 , we investigated the influence of cmsA and cmsB disruption on OMGM structure. Since the presence of β-(1 → 5)-/β-(1 → 6)-galactofuranosyl residues in OMGM prevents the determination of mannosyl chain length, we constructed ∆glfA∆cmsA and ∆glfA∆cmsB strains to reveal alterations in the length of mannosyl chain by cmsA or cmsB disruption (Fig. S4 ). We extracted total GMs from ∆glfA, ∆glfA∆cmsA, and ∆glfA∆cmsB strains, released OMGMs by β-elimination treatment, and evaluated the lengths of these released OMGMs by gel filtration chromatography (Bio-Gel P-2 column, 2 × 90 cm, Bio-rad) ( Fig. 7) with detection using the phenol-sulfuric acid method. Mannobiose residues were detected in the OMGMs both from ∆glfA∆cmsA and ∆glfA∆cmsB strains (Fig. 7) , indicating that neither CmsA nor CmsB is involved in the biosynthesis of OMGM α-(1 → 2)-mannosyl residues in vivo.
Involvement of CmsA and CmsB in FTGM core-mannan biosynthesis in vivo.
To examine the effects of cmsA and cmsB gene disruption on FTGM structure, we extracted and purified total GMs from WT A1151, ∆cmsA, ∆cmsB, ∆cmsAB, ∆cmsA::cmsA, and ∆cmsB::cmsB strains. The extracted total GMs containing both FTGM and OMGM (designated FTGM + OMGM) were then subjected to β-elimination to remove OMGM to designate FTGMs. First, FTGMs were analyzed to determine their carbohydrate compositions (Fig. 8) . FTGMs extracted from A1151 (WT-FTGM) were entirely composed of Man (33.8 ± 1.3%), galactose (Gal) (25.3 ± 6.6%), and glucose (40.9 ± 5.8%) residues (Fig. 8A ). This result is consistent with previous reports that FTGM is covalently bound to the branched β-(1 → 3)-glucan 1, 11 . The calculated Man/Gal ratios in the FTGMs are shown in Fig. 8 . The Man/Gal ratios of ∆cmsA, ∆cmsB, ∆cmsAB were noticeably lower than those of A1151 (Fig. 8B) . Next, the resultantly purified FTGMs were analyzed using 1 H-NMR spectroscopy. A strong signal at 5.195 ppm (G in Fig. S5 ) was detected in 1 H-NMR spectra from all three disruptant strains. This G peak represents the H-1 at the C-1 position of the underlined Galf residue in -β-Galf-(1 → 5)-β-Galf-(1 → 5)-β-Galf-(1 → 5)-according to a previous report 6 . This result indicates that the Galf sugar chain in FTGM remains even if cmsA, cmsB, or both genes are disrupted. Thus, to remove galactofuranosyl residues from FTGM, FTGM fractions were subjected to acid hydrolysis and the products (designated FTGM-HCls) analyzed by 1 H-NMR spectroscopy (Fig. 9) . 
, respectively, according to a previous report 6 . In contrast, these core-mannan signals were absent or substantially truncated in the 1 H-NMR spectra for ∆cmsA-FTGM-HCl, ∆cmsB-FTGM-HCl, and ∆cmsAB-FTGM-HCl, indicating that core-mannan structures are altered and/or lost in the absence of cmsA or cmsB (Fig. 9) . A weak signal designated D′ at 5.05 ppm was detected in the 1 H-NMR spectra for ∆cmsA-FTGM-HCl, ∆cmsB-FTGM-HCl, and ∆cmsAB-FTGM-HCl, while another faint signal designated A′ at 5.1 ppm was detected in the 1 H-NMR spectra for ∆cmsB-FTGM-HCl and ∆cmsAB-FTGM-HCl (Fig. 9) . Signals A′ and D′ are from H-1 at the C-1 position of the underlined Man residue in t-Man-(1 → 6)-α-Man-and t-Man-(1 → 2)-α-Man- 6, 30 . Thus, A′ and D′ indicate the presence of α-(1 → 6)-linked and α-(1 → 2)-linked terminal mannosyl residues, respectively, suggesting that shorter oligomannan structures are present in the deletion mutants. The signals A, B, C, and D found in the spectrum from WT-FTGM-HCl were restored in the 1 H-NMR spectra for the complementary strains ∆cmsA::cmsA and ∆cms-B::cmsB (Fig. 9) ∆glfA∆cmsB, in which Galf sugar chains are absent (Fig. S6) . These results indicate that core-mannan structures in FTGMs are drastically altered and shortened in the disruptant strains ∆cmsA, ∆cmsB, and ∆cmsAB. Next, these FTGM-HCls were analyzed by gel filtration chromatography using a Sephacryl S-200 HR column (1 × 75 cm) and detection by the phenol-sulfuric acid method. Peak FTGM-HCl content in the WT A1151 strain was detected from fractions 35 to 50 (Fig. 10) . In ∆cmsA, ∆cmsB, and ∆cmsAB, the molecular weights of FTGM-HCls were shifted downward (Fig. 10) , while the gene complemented strains ∆cmsA::cmsA and ∆cms-B::cmsB restored the molecular masses of FTGM-HCls similar to those of WT (Fig. 10) . Similar chromatograms were obtained for FTGMs extracted from strains ∆glfA∆cmsA and ∆glfA∆cmsB (Fig. S7) . These results indicate that the average molecular weights of FTGM-HCl are reduced in the absence of cmsA and cmsB. Taken together, these results indicate that CmsA is an α-1,2-mannosyltransferase that is responsible for FTGM core-mannan biosynthesis and CmsB is a putative α-1,2-mannosyltransferase responsible for FTGM core-mannan biosynthesis. 
Discussion
We elucidated that CmsA has α-1,2-mannosyltransferase using in vitro mannosyltransferase assay and substrate-specific-mannosidase analysis (Figs 2 and S1 ). On the contrary, we could not obtain soluble CmsB recombinant proteins using E. coli expression systems. CmsB protein has 42% amino acid sequence identities with an α-1,2-mannosyltransferase, ScKtr7 protein and 37.5% amino acid sequence identities with CmsA. Therefore, it is speculated that CmsB also has α-1,2-mannosyltransferase activity in vitro and in vivo. However, detailed analyses will be required for the identification of the enzymatic function of CmsB. 1 H-NMR spectroscopy and gel filtration chromatography revealed that CmsA and CmsB are required for the biosynthesis of FTGM core-mannan (Figs 9, 10 and S6, S7). Because the phenotypes of ∆cmsA are similar to those of ∆cmsB, these enzymatic functions may not be redundant. Therefore, it is believed that CmsA and CmsB are involved in the transfer of mannose residues at different positions in FTGM. Because glycans are sequentially biosynthesized, CmsB is likely involved in mannose transfer during the early stages of FTGM biosynthesis. CmsA demonstrated weaker elongation activity toward α-(1 → 2)-mannobiose than toward α-(1 → 6)-mannobiose in vitro (Fig. 2C) . The result indicates that in the FTGM structure, CmsA is responsible for transferring the mannose to the C-2 position of the α-mannose residue at the non-reducing side of α-(1 → 6)-mannobiose. Further, the possibility that CmsB primarily acts as an elongation enzyme of α-(1 → 2)-mannobiose in vivo cannot be excluded. However, functional differences between CmsA and CmsB are unknown, necessitating further detailed analysis. Nonetheless, there is no doubt that CmsA and CmsB are involved in the biosynthesis of the FTGM core-mannan. Notably, β-(1 → 5)-galactofuranosyl chains were retained in FTGM (β-eliminated GM) extracted from ∆cmsA and ∆cmsB, indicating that not all β-(1 → 5)-galactofuranosyl chains are bound to the core-mannans of FTGM and OMGM (Fig. S5) . It is conceivable that some β-(1 → 5)-galactofuranosyl chains are bound to unknown sugar chain structures.
Wagener et al. reported that afmnt1 (Afu5g10760/AFUB_058360 gene) is a putative α-1,2-mannosyltransferase and is required for cell wall stability 21 . A ∆afmnt1 strain exhibited increased sensitivity to cell wall stress, high temperature, and calcofluor white and Congo red staining 21 . However, the ∆afmnt1 mutant normally grows under normal growth conditions 21 . In contrast, both ∆cmsA and ∆cmsB abnormally grow, and their growth defects are considerable. This observation suggests that the function of AfMnt1 is different than that of both CmsA and CmsB. However, the enzymatic function(s) of AfMnt1 have yet to be elucidated, necessitating further detailed analysis. Recently, a multiple deletion mutant of 11 putative mannosyltransferases other than cmsA and cmsB that is responsible for establishing α-(1 → 6)-and α-(1 → 2)-mannose linkages in yeast was constructed in A. fumigatus 31 . The mutant did not reduce the mannan content of the mycelium cell wall but reduced the mannan content of the conidial cell wall 31 . The mutant did not exhibit drastic mycelial growth defects 31 . Therefore, core-mannan constructed by CmsA and CmsB seemingly plays an important role in mycelial cell wall maintenance rather than these 11 mannosyltransferases.
Orthologs of cmsA and cmsB are also present in many pathogenic fungi that cause plant and animal diseases, such as the animal pathogens Trichophyton rubrum, Paracoccidioides brasiliensis, and Ajellomyces capsulatus and the plant pathogens Magnaporthe grisea, Fusarium graminearum, and Botrytis cinerea. There are a few previous reports on phenotypic changes conferred by disruption of cmsA and/or cmsB orthologs. In Neurospora crassa, strong growth inhibition was observed by disruption of the cmsA ortholog 32 , suggesting common functions for CmsA in filamentous fungi. However, in the insect pathogenic fungus Beauveria bassiana, disruption of the cmsA ortholog ktr4 or cmsB ortholog ktr1 did not cause drastic growth inhibition 33 , suggesting that cmsA and cmsB have different functions in B. bassiana or that core-mannan elaborated by CmsA and CmsB does not play an important role in B. bassiana development. Loss of the core-mannan chain was associated with abnormal structures of hyphae and conidiophore as well as reduced conidia formation, indicating that the core-mannan chain plays an important role in the normal formation of hyphal and conidiophore cell walls (Figs 4-6) . Reportedly, similar phenotypes are also observed in disrupted strains of the genes involved in the biosynthesis of GDP-Man, a sugar donor of CmsA and CmsB [34] [35] [36] . A similar balloon structure was also reported in other cell wall-deficient strains, for example, strains missing chitin-synthase with myosin domain (csmA) 37 , protein O-mannosyltransferase A and C (pmtA and pmtC) [38] [39] [40] . Given that core-mannan deficiency decreases the physical strength of the cell wall, strains ∆cmsA and ∆cmsB may not be able to withstand the osmotic pressure of the external environment, resulting in formation of the observed balloon structure. Disruption of cmsA and cmsB also repressed hyphae extension, suggesting that CmsA and/or CmsB inhibitors may be effective antifungal drugs. FTGM is a sugar chain structure specific to fungi and does not exist in humans or plants (that do not possess homologous enzymes). Thus, we assume that the α-1,2-mannosyltransferases involved in FTGM biosynthesis are potential targets for use in novel antifungal therapies. Moreover, cmsA and/or cmsB disruptant strains demonstrated increased susceptibility to several clinical antifungal drugs (AMPH-B, ITCZ, MCZ, and 5-FC), suggesting that CmsA and/or CmsB inhibitors may enhance the therapeutic efficacy of these compounds (Table 2 ).
In conclusion, the deletion of CmsA, α-1,2-mannosyltransferase, and/or CmsB, putative α-1,2-mannosyltransferase involved in FTGM biosynthesis, induces severe developmental impairments and increases susceptibility to several existing antifungal drugs. This suggests the possibility of developing new drugs targeting α-1,2-mannosyltransferase to combat fungal pathogens in medicine and agriculture.
Materials and Methods
Microorganisms and growth conditions. The A. fumigatus strains used in this study are listed in Table 1 .
Aspergillus fumigatus strains A1160 and A1151 were obtained from the Fungal Genetics Stock Center (Kansas City, MO) and grown on MM composed of 1% glucose, 0.6% NaNO 3 , 0.052% KCl, 0.052% MgSO 4 ·7H 2 O, and 0.152% KH 2 PO 4 plus Hunter's trace elements (in w/v; pH 6.5). Aspergillus strains were transformed using Construction of expression vectors for CmsA and CmsB. Bacterial codon-optimized cmsA (AFUB_051270) and cmsB (AFUB_059750) genes from A. fumigatus A1163 were synthesized by Bioneer (Korea).
The cmsA gene was delivered by Bioneer cloned in a pBT7-N-His vector with an N-terminal 6 × His tag, termed pBT7-CmsA. The pBT7-CmsA was used for recombinant protein production. The cmsB gene was amplified by PCR and cloned into pET15b-KAI 9 . The cmsB gene was amplified by PCR using the cloned synthesized cmsB gene as a template for the primers pET15b-CmsB(CO)-IF-F and pET15b-CmsB(CO)-IF-R (Table S1 ). The amplified fragment was inserted between the Nde I and Not I sites of pET15b-KAI by in-fusion HD cloning kit (TAKARA, Japan) to yield pET15b-CmsB. All PCR reactions were performed using Phusion High-Fidelity DNA Polymerase (New England Biolabs, USA). The pBT7-CmsA and pET15b-CmsB plasmids were transformed into Rosetta-gami B (DE3) cells.
Protein purification, quantification, and electrophoresis. Protein purification was performed as previously described 9 . Protein concentrations were determined using the Qubit Protein Assay Kit (Thermo Fisher Scientific, USA), and CmsA and CmsB were analyzed by SDS-PAGE to assess purity and molecular weight.
Enzyme assays. The artificial acceptor substrate p-nitrophenyl α-d-mannopyranoside (α-Man-pNP) was purchased from Sigma-Aldrich (USA). Alpha-(1 → 2)-mannobiose and α-(1 → 6)-mannobiose were purchased from Dextra Laboratories Ltd (United Kingdom). Standard assays were performed with α-Man-pNP, α-(1 → 2)-mannobiose or α-(1 → 6)-mannobiose as acceptor, GDP-Man as donor, and purified CmsA protein in a total reaction volume of 20 µl. The mixture was incubated at 37 °C and stopped by heating (99 °C) for 5 min. Para-nitrophenol derivatives were detected by UV 300 absorbance and analyzed by HPLC using a Shodex Asahipak NH2P-50 4E amino column (250 × 4.6 mm; Showa Denko, Japan) as previously described 9 . Alpha-(1 → 2)-mannobiose or α-(1 → 6)-mannobiose derivatives were labeled using 2-aminopyridine (PA) after reaction as previously described, with slight modifications 41 . Reaction mixtures were dried using a centrifugal concentrator, and the resulting samples were dissolved in 20 µL of PA reagent (110.4 mg of PA in 40 µL of glacial acetic acid) and incubated at 90 °C for 1 h. The samples were then mixed with 70 µL of PA reducing reagent (200 mg borate-dimethylamine complex in 80 µL of glacial acetic acid and 50 µL of ultra-pure water) and incubated at 80 °C for 35 min. Next, 500 µL of 0.2 M ammonia solution and 300 µL of chloroform were added to the resulting sample. Following centrifugation, the supernatant was designated as the PA-sugars. The PA-sugars were purified with a Monospin PBA spin column (GL Science, Tokyo, Japan) as previously described 42 . The purified PA-sugars were detected via fluorescence at excitation and emission wavelengths of 310 nm and 380 nm, respectively, and analyzed using HPLC with a Shodex Asahipak NH2P-50 4E amino column (250 × 4.6 mm) as follows. Elution was performed using two solvents: eluent A, 93% acetonitrile in 0.3% acetate (pH adjusted to 7.0 with ammonia), and eluent B, 20% acetonitrile in 0.3% acetate (pH adjusted to 7.0 with ammonia). The gradient program was set at a flow rate of 0.8 mL/min (expressed as the percentage of solvent B): 0-5 min, isocratic 3%; 5-30 min, 3-40%; 30-35 min, 40-3%; 35-60 min, isocratic 3%. Enzymatic activity was evaluated by determining the area of products via HPLC. Oligosaccharide levels were compared to α-Man-pNP, α-(1 → 2)-mannobiose or α-(1 → 6)-mannobiose as a standard. Alpha-1,2-mannosidase and α-1,6-mannosidase were purchased from ProZyme (USA) and New England Biolabs (USA), respectively, and used according to the manufacturers' instructions.
Construction of ∆cmsA and ∆cmsB gene disruption strains. A. fumigatus A1160 was used as the parental strain (Table 1) to construct ∆cmsA and ∆cmsB strains by AnpyrG insertion (Fig. S2A) . DNA fragments for the gene disruption were constructed using a "double-joint" PCR method as previously described 43 . All PCRs were performed using Phusion High-Fidelity DNA Polymerase and the oligonucleotide primers listed in Table S1 . Eight primers, AFUB_051270-1 to AFUB_051270-4, AFUB_051270-7, AFUB_051270-8, pyrG-5, and pyrG-6, were used to construct a deletion cassette for ∆cmsA. Similarly, eight primers, AFUB_059750-1 to AFUB_059750-4, AFUB_059750-7, AFUB_059750-8, pyrG-5, and pyrG-6, were used to construct a deletion cassette for ∆cmsB. The 5′-and 3′-flanking regions (approximately 1.0 kb each) of cmsA were PCR amplified from genomic DNA with primer pairs AFUB_051270-1/AFUB_051270-2 and AFUB_051270-3/AFUB_051270-4. The 5′-and 3′-flanking regions (approximately 1.0 kb each) of cmsB were PCR amplified from genomic DNA with primer pairs AFUB_059750-1/AFUB_059750-2 and AFUB_059750-3/AFUB_059750-4. The AnpyrG gene used as a selective marker was amplified using plasmids pSH1 as template 13 and the primer pairs pyrG-5/pyrG-6. The three amplified fragments were purified, mixed, and subjected to a second PCR without specific primers to assemble each fragment as the overhanging chimeric extensions act as primers. A third PCR was performed with the nested primer pairs AFUB_051270-7/AFUB_051270-8 for cmsA or AFUB_059750-7/AFUB_059750-8 for cmsB and the products of the second PCR used as templates to generate the final deletion constructs. The amplified final deletion constructs were purified using the Fast Gene Gel/PCR Extraction Kit (NIPPON GENE, Japan) and used directly for transformation of A. fumigatus. Transformants were grown on MM plates containing 0.6 M KCl as an osmotic stabilizer under appropriate selection conditions, and single colonies were isolated twice before further analysis. Correct replacement of the DNA fragments for gene complementation was confirmed by PCR using the primer pairs AFUB_051270-1/pyrG-R and pyrG-F/AFUB_051270-4 for cmsA and the primer pairs AFUB_059750-1/pyrG-R and pyrG-F/AFUB_059750-4 for cmsB (Fig. S2B) . At least three of these mutants were independently constructed.
Construction of the ∆cmsA∆cmsB (∆cmsAB) double gene disruption strain. A. fumigatus ∆cmsA was used as the parental strain (Table 1) to construct the cmsA and cmsB double gene disruption strain (∆cmsAB).
The cmsB gene was disrupted in A. fumigatus ∆cmsA strain by ptrA insertion (Fig. S2A) . The 5′-and 3′-flanking regions (approximately 1.0 kb each) of cmsB were PCR amplified from genomic DNA with primer pairs AFUB_059750-1/AFUB_059750-2P and AFUB_059750-3P/AFUB_059750-4. The ptrA gene used as a selective marker was amplified using plasmid pPTR-I (Takara) as template and the primer pair ptrA-5/ptrA-6. Disruption of cmsB was confirmed by PCR using the primer pairs AFUB_059750-1/ptrA-R and ptrA-F/AFUB_059750-4 ( Fig. S2B) . At least three of these mutants were independently constructed.
Construction of ∆cmsA and ∆cmsB complementary strains (∆cmsA::cmsA and ∆cmsB::cmsB).
A. fumigatus ∆cmsA and ∆cmsB were used as the host strains (Table 1) for constructing the complemented strains (Fig. S3A ). All PCR assays were performed using Phusion High-Fidelity DNA Polymerase. Eight primers (AFUB_051270-1, AFUB_051270-complement-2, complement-3, complement-4, complement-8, AFUB_051270-7, ptrA-F, and ptrA-R) were used to construct a complementation cassette for cmsA and eight primers (AFUB_059750-1, AFUB_059750-complement-2, complement-3, complement-4, complement-8, AFUB_059750-7, ptrA-F, and ptrA-R) to construct a complementation cassette for cmsB. The regions of the cmsA and cmsB gene were PCR amplified from genomic DNA using the primer pairs AFUB_051270-1/AFUB_051270-complement-2 and AFUB_059750-1/AFUB_059750-complement-2, respectively. The region of the pyrG gene from A. nidulans (AnpyrG) was PCR amplified from pSH1 using the primer pair complement-3/complement-4. The ptrA genes used as selective markers were amplified using the pPTR-I plasmid as a template and the primer pair ptrA-5/ptrA-6. Analysis of conidiation efficiency. The efficiency of conidiation was analyzed as described previously 13 . Briefly, approximately 10 5 conidia were spread onto MM plates (90 mm diameter). After 3 days of incubation at 37 °C, the conidia were suspended in 15 ml of 0.01% (w/v) Tween 20 and counted using a hemocytometer. Efficiency was quantified as the number of conidia formed per unit area.
Drug susceptibility testing. Drug susceptibility was tested in triplicate according to the Clinical and Laboratory Standards Institute reference broth microdilution method (document M38-A2) 46 , with minor modifications. Briefly, dried plates were used for antifungal susceptibility testing (Eiken Chemicals, Japan) 47 .
Software and database searches. The transmembrane regions of CmsA and CmsB were predicted by the TMHMM tool (http://www.cbs.dtu.dk/services/TMHMM/) 23 . BLAST searches were performed by a tool in Aspergillus genome database (AspGD) (http://www.aspergillusgenome.org) 22 .
